Boala Crohn este o afecțiune cronică, cu perioade de remisiune și recurență a simptomelor, și poate duce la complicații ...

Nick Blackmer is a librarian, fact-checker, and researcher with more than 20 years of experience in consumer-facing health and wellness content. It can be difficult to discuss Crohn’s, a type of ...

Crohn’s disease is a type of inflammatory bowel disease (IBD) that causes inflammation in the digestive tract. The inflammation can lead to symptoms like abdominal pain, diarrhea, weight loss, a ...

June 10, 2024 — Scientists have grown 'mini-guts' in the lab to help understand Crohn's disease, showing that 'switches' that modify DNA in gut cells play an important role in the disease ...

However, this article will focus on three other digestive disorders: irritable bowel syndrome (IBS), and Crohn’s and Colitis — exploring their causes, symptoms, and treatment options, both medical and ...

A Cullercoats man is thanking NHS staff after making a miraculous recovery only a week later from a six-hour surgery for Crohn's disease. After a tumultuous 18-months which saw his health take a ...

Multiple failings led to a patient with Crohn's disease having a hysterectomy without giving informed consent, an ombudsman has found. The woman, in her early 40s, said it has left her feeling ...

Imagini distribuite pe rețelele de socializare arată cum tânărul este escortat într-o mașină de doi ofițeri care poartă haine de poliție. „Administrația Trump l-a reținut pe Mohsen Mahdawi ca ...

Noi imagini video cu unul dintre avioanele de luptă futuriste ale Chinei, un aparat cu trei motoare și aripă zburătoare fără coadă, pe care analiștii occidentali l-au botezat J-36, au apărut pe ...

Johnson & Johnson's IL-23 inhibitor Tremfya has been approved by the FDA as a treatment for Crohn's disease, becoming the first drug in the class available in both intravenous and subcutaneous ...

Eli Lilly has claimed FDA approval for its IL-23 inhibitor Omvoh as a treatment for moderately to severely active Crohn's disease, extending its use beyond ulcerative colitis (UC) for the first time.